Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) COO Sells $225,940.00 in Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,430 shares of ICU Medical stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.00, for a total value of $225,940.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Christian B. Voigtlander also recently made the following trade(s):

• On Monday, November 25th, Christian B. Voigtlander sold 1,962 shares of ICU Medical stock. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96.

ICU Medical Trading Up 2.6 %

Shares of ICUI stock opened at $163.96 on Friday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12-month low of $83.26 and a 12-month high of $196.26. The stock has a market capitalization of $4.01 billion, a P/E ratio of -35.88 and a beta of 0.66. The firm’s 50 day moving average is $174.85 and its 200 day moving average is $146.69.

Analysts Set New Price Targets

ICUI has been the topic of several analyst reports. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They issued a “hold” rating and a $183.00 price objective on the stock. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp upped their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. Finally, Raymond James increased their price objective on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, ICU Medical has an average rating of “Moderate Buy” and a consensus price target of $173.00.

Hedge Funds Weigh In On ICU Medical

Hedge funds and other institutional investors have recently modified their holdings of the company. Franklin Resources Inc. grew its holdings in shares of ICU Medical by 99.3% in the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock worth $2,111,000 after acquiring an additional 5,834 shares during the period. Coldstream Capital Management Inc. bought a new stake in shares of ICU Medical during the 3rd quarter valued at about $227,000. Geode Capital Management LLC increased its position in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after purchasing an additional 48,106 shares during the last quarter. Barclays PLC lifted its stake in shares of ICU Medical by 15.6% in the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after purchasing an additional 8,010 shares during the period. Finally, XTX Topco Ltd purchased a new position in shares of ICU Medical in the third quarter worth approximately $342,000. 96.10% of the stock is owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.